Introduction
Methods
Results
GRF | CL 1 | CL 2 | p Value | ||
---|---|---|---|---|---|
Subjects per Cluster
| 11 | 32 | |||
Mean and St. Dev
| |||||
Year of Disease
| 16,73 | 10,80 | 20,68 | 12,61 | |
HbA1c
| 7,97 | 1,26 | 7,96 | 1,14 | |
Presence of Complications
| |||||
Vasculopathy
| 3 (27.27%) | 5 (15.625%) | |||
microalbuminuria
| 2 (18.18%) | 4 (12.5%) | |||
Neuropathy
| 3 (27.27%) | 17 (53.125%) | |||
Autonomic Neuropathy
| 2 (18.18%) | 7 (21.875%) | |||
Finger Deformity
| 1 (9.09%) | 13 (40.625%) | |||
Callosity
| 2 (18.18%) | 18 (56.25%) | 0,02926 | ||
Ulcer
| 0 | 3(9.37%) | |||
KINEMATICS
|
CL 1
|
CL 2
|
p Value
| ||
Subjects per Cluster
| 18 | 26 | |||
Mean and St. Dev
| |||||
Year of Disease
| 23,67 | 11,82 | 16,44 | 11,56 | |
HbA1c
| 7,95 | 1,27 | 7,97 | 1,11 | |
Presence of Complications
| |||||
Vasculopathy
| 3 (16.67%) | 5 (19.23%) | |||
microalbuminuria
| 3 (16.67%) | 3 (11.54%) | |||
Neuropathy
| 6 (33.33%) | 8 (30.77%) | |||
Autonomic Neuropathy
| 10 (55.56%) | 10 (38.46%) | |||
Finger Deformity
| 12 (66.67%) | 9 (34.62%) | 0,03662 | ||
Callosity
| 5 (27.78%) | 4 (15.39%) | |||
Ulcer
| 0 | 3(11.5%) |